PHILADELPHIA—Three women who developed breast cancer after taking the hormone replacement drug Prempro Dec. 8 reached a confidential settlement with Pfizer Inc., two days after a state jury in Philadelphia awarded the women a total of $72.5 million in compensatory damages in their consolidated lawsuit against the drug’s manufacturer (Elfont v. Wyeth Pharmaceuticals Inc.).
Prempro is made by Wyeth Pharmaceuticals Inc., which was acquired by Pfizer in 2009.
“We were very pleased” with the settlement, attorney Leonard Lundy, of Lundy Law, in Philadelphia, an attorney for the plaintiffs, told BNA Dec. 9.
In the initial phase of the ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.